Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

Nature

Volumn 445, Issue 7125, 2007, Pages 319-323

  Kobasa, Darwyn ^a   Jones, Steven M ^b,c   Shinya, Kyoko ^d   Kash, John C ^e   Copps, John ^g   Ebihara, Hideki ^b,h,i   Hatta, Yasuko ^j   Kim, Jin Hyun ^j   Halfmann, Peter ^j   Hatta, Masato ^j   Feldmann, Friederike ^b   Alimonti, Judie B ^b   Fernando, Lisa ^b   Li, Yan ^a   Katze, Michael G ^e,f   Feldmann, Heinz ^b,c   Kawaoka, Yoshihiro ^h,i,j  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d TOTTORI UNIVERSITY   (Japan)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g Public Health Agency of Canada   (Canada)

^h UNIVERSITY OF TOKYO   (Japan)

ⁱ JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^j UNIVERSITY OF WISCONSIN MADISON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNE RESPONSE; INFLUENZA; PATHOGENICITY; PHENOTYPE; PRIMATE; RESPIRATORY DISEASE; VIRAL DISEASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOMODULATION; INFLUENZA; INFLUENZA VIRUS; INNATE IMMUNITY; MACACA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RESPIRATORY TRACT INFECTION; VIRUS INFECTIVITY; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALIA; AVES; MACACA; MUS; ORTHOMYXOVIRIDAE; PRIMATES;

EID: 33846265834     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05495     Document Type: Article

References (30)

1. Johnson, N. P. & Mueller, J. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull. Hist. Med. 76, 105-115 (2002).
2. Tumpey, T. M. et al. Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc. Natl Acad. Sci. USA 99, 13849-13854 (2002).
3. Kobasa, D. et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431, 703-707 (2004).
4. Tumpey, T. M. et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310, 77-80 (2005).
5. Seo, S. H., Hoffmann, E. & Webster, R. G. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nature Med. 8, 950-954 (2002).
6. Reid, A. H., Fanning, T. G., Hultin, J. V. & Taubenberger, J. K. Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene. Proc. Natl Acad. Sci. USA 96, 1651-1656 (1999).
7. Reid, A. H., Fanning, T. G., Janczewski, T. A. & Taubenberger, J. K. Characterization of the 1918 "Spanish" influenza virus neuraminidase gene. Proc. Natl Acad. Sci. USA 97, 6785-6790 (2000).
8. Basler, C. F. et al. Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc. Natl Acad. Sci. USA 98, 2746-2751 (2001).
9. Reid, A. H., Fanning, T. G., Janczewski, T. A., McCall, S. & Taubenberger, J. K. Characterization of the 1918 "Spanish" influenza virus matrix gene segment. J. Virol. 76, 10717-10723 (2002).
10. Reid, A. H., Fanning, T. G., Janczewski, T. A., Lourens, R. M. & Taubenberger, J. K. Novel origin of the 1918 pandemic influenza virus nucleoprotein gene. J. Virol. 78, 12462-12470 (2004).
11. Taubenberger, J. K. et al. Characterization of the 1918 influenza virus polymerase genes. Nature 437, 889-893 (2005).
12. Neumann, G. et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl Acad. Sci. USA 96, 9345-9350 (1999).
13. Rimmelzwaan, G. F. et al. Pathogenesis of influenza A (H5N1) virus infection in a primate model. J. Virol. 75, 6687-6691 (2001).
14. Kuiken, T., Rimmelzwaan, G. F., Van Amerongen, G. & Osterhaus, A. D. Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis). Vet. Pathol. 40, 304-310 (2003).
15. Winternitz, M. C., Wason, I. M. & McNamara, F. P. The Pathology of Influenza. (Yale Univ. Press, New Haven, Connecticut, 1920).
16. Hayden, F. G. et al. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J. Clin. Invest. 101, 643-649 (1998).
17. Skoner, D. P., Gentile, D. A., Patel, A. & Doyle, W. J. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. J. Infect. Dis. 180, 10-14 (1999).
18. Kash, J. C. et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443, 578-581 (2006).
19. de Jong, M. D. et al. Fatal outcome of human influenza A(H5N1) is associated with high viral load and hypercytokinemia. Nature Med. 12, 1203-1207 (2006).
20. Matikainen, S. et al. Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J. Virol. 80, 3515-3522 (2006).
21. Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101-105 (2006).
22. Garcia-Sastre, A. et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252, 324-330 (1998).
23. Krug, R. M., Yuan, W., Noah, D. L. & Latham, A. G. Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. Virology 309, 181-189 (2003).
24. Li, S., Min, J. Y., Krug, R. M. & Sen, G. C. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349, 13-21 (2006).
25. Pichlmair, A. et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′ phosphates. Science 314, 997-1001 (2006).
26. Baas, T. et al. Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics. J. Virol. 80, 10813-10828 (2006).
27. Reed, L. J. & Muench, H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27, 493-497 (1938).
28. Kash, J. C. et al. Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence. J. Virol. 80, 3009-3020 (2006).
29. Brazma, A. et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nature Genet. 29, 365-371 (2001).
30. Al-Shahrour, F., Minguez, P., Vaquerizas, J. M., Conde, L. & Dopazo, J. BABELOMICS: a suite of web tools for functional annotation and analysis of groups of genes in high-throughput experiments. Nucleic Acids Res. 33, W460-W464 (2005).